SOMERSET, N.J., Nov. 17, 2009 (GLOBE NEWSWIRE) -- inVentiv Health (Nasdaq:VTIV) is pleased to announce that four of its companies recently won top honors at the first-ever 2009 CLIO Healthcare Awards, an extension of The CLIO Awards, one of the world's most recognized award competitions for advertising, design and interactive. The awards were announced on November 13 in New York City.
inVentiv Health companies took home more CLIO awards than any other advertising agency network.
GSW Worldwide was honored with two silver awards in the Direct to Consumer Disease Awareness print category for their work with Takeda's Uloric for 'Flares Aren't the Whole Story,' and 'A (Slightly Confusing) History of Eczema' for Astellas' Protopic. The agency also took home silver for Covidien's 'Dosing Matters' in the Direct to Professional (DTP) print category. The agency's work for Ethicon Endo-Surgery, Inc's 'Ligamax 5- Test Center' was named a finalist in the DTP device and diagnostics category.
Pink Tank, a specialty division of GSW Worldwide that focuses on women and health, was awarded bronze for their corporate self-promotion print campaign. The division's website, www.knowher.com, was recognized as a finalist in the Direct to Professional interactive category.
Ignite Health was awarded silver in the Direct to Consumer Disease Awareness category for www.livewithit.com, a serial Web miniseries that utilizes hand-drawn character animations and intertwining storylines to tell the story of five diverse people whose lives intersect at a support group by a shared circumstance of living with HIV/AIDS.
Palio was honored with a silver award in the Direct to Consumer poster campaign category for 'GRACE -- Greatest Generations', a philanthropic campaign that pays tribute, and gives a sneak peek into the lives and times of the Greatest Generation.
Chandler Chicco Agency (CCA), a global healthcare public relations firm, was awarded silver in the Direct to Professional strategic communications category for their work with Novartis 'The Christopher Film Series,' a series of original short films depicting a young adult living with cystic fibrosis (CF) as he struggles with transition to adulthood.
"This prestigious recognition is truly an honor for inVentiv Communications and a tribute to the dedicated individuals who continually produce such great work throughout our network of companies," said Bill O'Donnell, President and COO of inVentiv Communications. "To be recognized by the first-ever CLIO Healthcare Awards is quite an amazing accomplishment for our organization, and we are thrilled to have clients who support our creativity and passion for creating great work."
The CLIO Healthcare Awards are produced by Nielsen Business Media, a part of The Nielsen Company, a leading global and media information company. For more information about the CLIO Healthcare Awards, visit www.CLIOHealthcare.com.
About inVentiv Health
inVentiv Health (Nasdaq:VTIV) is the leading provider of commercialization and complementary services to the healthcare industry globally. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including the top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.